Amgen Correlations

AMGN Stock  USD 325.28  3.37  1.05%   
The current 90-days correlation between Amgen Inc and Merck Company is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Amgen Correlation With Market

Very weak diversification

The correlation between Amgen Inc and DJI is 0.54 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Amgen Inc and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Moving together with Amgen Stock

  0.7DTIL Precision BioSciencesPairCorr

Moving against Amgen Stock

  0.47DRUG Bright Minds BiosciencesPairCorr
  0.48SABSW SAB BiotherapeuticsPairCorr
  0.35VSTM VerastemPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
BIIBMRK
BMYGILD
LLYMRK
BIIBLLY
PFEMRK
PFEJNJ
  
High negative correlations   
BIIBBMY
BIIBGILD
BMYMRK
GILDMRK
LLYBMY
LLYGILD

Risk-Adjusted Indicators

There is a big difference between Amgen Stock performing well and Amgen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Amgen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Amgen Corporate Management

Linda LouieVP OfficerProfile
James MDExecutive OfficerProfile
Nancy GrygielSenior OfficerProfile
Justin ClaeysVice RelationsProfile